Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metronidazole: proven benefits and potential risks

P Goldman

    The Johns Hopkins Medical Journal
    |July 1, 1980
    PubMed
    Summary

    Metronidazole is effective for various infections but carries mutagenic risks. Its metabolites, formed in gut flora, indicate potential risks in humans, warranting cautious use and further investigation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Population Genomics of <i>Macrophomina</i> spp. Reveals Cryptic Host Specialization and Evidence for Meiotic Recombination.

    Molecular plant-microbe interactions : MPMI·2025
    Same author

    Bacterial Blight on Arugula, a New Disease Caused by Pseudomonas syringae pv. Alisalensis in California.

    Plant disease·2019
    Same author

    Inhibition of monoamine oxidase by furazolidone in germfree rats.

    Biochemical pharmacology·2010
    Same author

    Interaction of amitriptyline with muscarinic receptor subtypes in the rat brain.

    Neurochemistry international·2010
    Same author

    The powerful placebo: doubting the doubters.

    Advances in mind-body medicine·2002
    Same author

    Physical activity in first-degree relatives of breast cancer patients.

    Journal of behavioral medicine·2002

    Area of Science:

    • Pharmacology
    • Microbiology
    • Toxicology

    Background:

    • Metronidazole is a vital drug for treating trichomoniasis, amebiasis, giardiasis, and anaerobic bacterial infections.
    • It's also used for antibacterial prophylaxis in colon surgery.
    • Concerns exist regarding metronidazole's mutagenic and tumorigenic potential in laboratory studies.

    Purpose of the Study:

    • To investigate the role of gut flora in metronidazole metabolism and its potential implications for human safety.
    • To identify specific metabolites of metronidazole produced by intestinal bacteria.

    Main Methods:

    • Analysis of metronidazole metabolites in conventional and germfree rats.
    • Detection of metabolites in human urine samples from patients treated with metronidazole.

    Main Results:

    • Two key metabolites, acetamide and N-(2-hydroxyethyl)-oxamic acid, were identified, formed via nitro group reduction in the intestinal flora.
    • These metabolites were present in conventional rats but absent in germfree rats, indicating flora-dependent formation.
    • Similar metabolites were detected in the urine of patients, suggesting in vivo relevance.

    Conclusions:

    • The reduction of metronidazole's nitro group in the gut flora is implicated in its biological activities, including mutagenicity.
    • Metronidazole metabolism in the gut flora may produce reactive intermediates or known carcinogens like acetamide.
    • While human cancer risk is likely low, cautious use of metronidazole in minimal effective doses is advised pending further investigation.

    Related Experiment Videos